Taaleri’s first bioindustry fund announces its first closing at EUR 80 million – the Finnish Climate Fund becomes an anchor investor in the fund

News

Taaleri Bioindustry I fund reached its target size of EUR 80 million in the first round of funding and continues fundraising backed up by strong demand. The fund complies with Article 9 of the EU Sustainable Finance Disclosure Regulation and is as such a so called dark green fund that only makes sustainable investments in projects that, for example, contribute substantially to climate change mitigation. The fund will start its investment activities immediately, and first investments are set to be made during the third quarter.

The Finnish Climate Fund, a state-owned special-assignment company, becomes an anchor investor in the bioindustry fund. The Climate Fund will invest EUR 10 million in the bioindustry fund now, and if the bioindustry fund reaches a total size of EUR 100 million, the Climate Fund will invest another EUR 5 million in the fund. The Climate Fund decided on the investment after a comprehensive due diligence assessment.

“We are very pleased with the success of the first round of funding and the Finnish Climate Fund’s decision to invest in our bioindustry fund. Aktia’s fundraising has been a success, so we reached the fund’s target size already in the first closing. The fundraising will continue, and the demand for sustainable investment products is strong”, says Tero Saarno, director of Taaleri Bioindustry. “Our bioindustry team has been building the project pipeline for more than a year, so we are ready to start investing immediately after the first closing.”

“Our investment into the bioindustry fund provides a way to get sorely needed financing for sustainable investments into the bioeconomy and circular economy, for example by encouraging private investors into joining. The participation of the Climate Fund as an anchor investor helps in setting up the fund and thus supports the development of the Finnish bioindustry,” says Paula Laine, CEO of the Finnish Climate Fund.

Taaleri Bioindustry I is a closed-end private equity fund with a 10-year term and a target size of EUR 80 million. The fund will invest in industrial-scale production facilities and companies that can accelerate the scaling of bioindustry production. Products can be, for example, bio- and recycled fibers, organic fertilizers, functional biomaterials, and recycled materials to replace virgin products.

Taaleri’s vision is to be a Nordic pioneer in alternative investments focusing on sustainability. We use capital and our expertise to build a better future, and in addition to bioindustry projects, we promote e.g. wind and solar power.

For further information, please contact:

Tero Saarno, director, Taaleri Bioindustry, +358 50 373 1923, tero.saarno@taaleri.com

 

Taaleri in brief

Taaleri is a Nordic investment and asset manager with an emphasis on renewable energy and other alternative investments. We channel capital towards economically profitable undertakings that have a lasting positive impact on the environment and society. We combine capital with talent, expertise, entrepreneurship, and a bold sense of purpose. We are a signatory of the UN Principles for Responsible Investment (UNPRI) since 2010, and we joined the Net Zero Asset Managers initiative in 2021. Taaleri’s vision is to be a Nordic forerunner in alternative investments focusing on sustainability.

Taaleri has two business segments: Private Asset Management and Strategic Investments. Private Asset Management consists of renewable energy, real estate and bioindustry businesses. The Strategic Investments segment includes Garantia Insurance Company Ltd.

Taaleri has EUR 2.3 bn of assets under management in its private equity funds and co-investments. The company has approximately 120 employees. Taaleri Plc is listed on Nasdaq Helsinki.

www.taaleri.com

Read next

News

Happy Plant Protein enables locally produced healthy and affordable plant-based food with new patented technology and raises EUR 1.8 million to go global

Researchers behind the innovation discovered a cost-effective way to produce high-quality plant protein based on existing extrusion technology. The new…
Read article